141 related articles for article (PubMed ID: 26920552)
1. Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis.
Onega T; Tosteson AN; Weiss J; Alford-Teaster J; Hubbard RA; Henderson LM; Kerlikowske K; Goodrich ME; O'Donoghue C; Wernli KJ; DeMartini WB; Virnig BA
BMC Health Serv Res; 2016 Feb; 16():76. PubMed ID: 26920552
[TBL] [Abstract][Full Text] [Related]
2. Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.
Killelea BK; Long JB; Chagpar AB; Ma X; Soulos PR; Ross JS; Gross CP
Breast Cancer Res Treat; 2013 Aug; 141(1):155-63. PubMed ID: 23942872
[TBL] [Abstract][Full Text] [Related]
3. Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer.
Onega T; Weiss JE; Buist DS; Tosteson AN; Henderson LM; Kerlikowske K; Goodrich ME; O'Donoghue C; Wernli KJ; DeMartini WB; Virnig BA; Bennette CS; Hubbard RA
Med Care; 2016 Jul; 54(7):719-24. PubMed ID: 27111752
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.
Henderson LM; Weiss J; Hubbard RA; O'Donoghue C; DeMartini WB; Buist DS; Kerlikowske K; Goodrich M; Virnig B; Tosteson AN; Lehman CD; Onega T
Breast J; 2016; 22(1):24-34. PubMed ID: 26511204
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer.
Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
J Clin Oncol; 2016 Feb; 34(4):321-8. PubMed ID: 26628465
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness of MR-imaging in the preoperative work-up of suspicious breast lesions].
Schmitt KP; Boehm T; Fleck M; Kaiser WA
Rofo; 2001 Oct; 173(10):898-901. PubMed ID: 11588676
[TBL] [Abstract][Full Text] [Related]
7. Preoperative breast MRI and mortality in older women with breast cancer.
Onega T; Zhu W; Weiss JE; Goodrich M; Tosteson ANA; DeMartini W; Virnig BA; Henderson LM; Buist DSM; Wernli KJ; Kerlikowske K; Hubbard RA
Breast Cancer Res Treat; 2018 Jul; 170(1):149-157. PubMed ID: 29516372
[TBL] [Abstract][Full Text] [Related]
8. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B
Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091
[TBL] [Abstract][Full Text] [Related]
9. The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women.
Goodrich ME; Weiss J; Onega T; Balch SL; Buist DS; Kerlikowske K; Henderson LM; Hubbard RA;
Breast J; 2016 Nov; 22(6):616-622. PubMed ID: 27550072
[TBL] [Abstract][Full Text] [Related]
10. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging.
Ozanne EM; Weiss JE; Onega T; DeMartini W; Kerlikowske K; Buist DS; Henderson L; Hubbard RA; Goodrich M; Tosteson AN; Virnig BA; O'Donoghue C
Am J Surg; 2017 Jan; 213(1):132-139.e2. PubMed ID: 27421187
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly.
Bateni SB; Gingrich AA; Jeon SY; Hoch JS; Thorpe SW; Kirane AR; Bold RJ; Canter RJ
J Surg Res; 2019 Jul; 239():125-135. PubMed ID: 30825757
[TBL] [Abstract][Full Text] [Related]
12. A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer.
Bedrosian I; Xing Y; Abdel Rahman S; Allen L; Le-Petross H; Whitman GJ; Meric-Bernstam F; Hunt KK; Babiera GV; Cormier JN
Ann Surg Oncol; 2016 Jan; 23(1):23-9. PubMed ID: 26156655
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
14. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.
Shirvani SM; Jiang J; Likhacheva A; Hoffman KE; Shaitelman SF; Caudle A; Buchholz TA; Giordano SH; Smith BD
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):605-16. PubMed ID: 27034179
[TBL] [Abstract][Full Text] [Related]
15. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780
[TBL] [Abstract][Full Text] [Related]
16. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE).
Turnbull LW; Brown SR; Olivier C; Harvey I; Brown J; Drew P; Hanby A; Manca A; Napp V; Sculpher M; Walker LG; Walker S;
Health Technol Assess; 2010 Jan; 14(1):1-182. PubMed ID: 20025837
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
Sail KR; Franzini L; Lairson DR; Du XL
Value Health; 2012 Jan; 15(1):72-80. PubMed ID: 22264974
[TBL] [Abstract][Full Text] [Related]
18. The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer.
Wang SY; Kuntz KM; Tuttle TM; Jacobs DR; Kane RL; Virnig BA
Breast Cancer Res Treat; 2013 Feb; 138(1):137-47. PubMed ID: 23354364
[TBL] [Abstract][Full Text] [Related]
19. Use of Preoperative Magnetic Resonance Imaging for Breast Cancer: A Canadian Population-Based Study.
Arnaout A; Catley C; Booth CM; McInnes M; Graham I; Kumar V; Simos D; Van Walraven C; Clemons M
JAMA Oncol; 2015 Dec; 1(9):1238-50. PubMed ID: 26402040
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
